727 related articles for article (PubMed ID: 8141730)
1. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies.
Morgan RW; Gelb J; Pope CR; Sondermeijer PJ
Avian Dis; 1993; 37(4):1032-40. PubMed ID: 8141730
[TBL] [Abstract][Full Text] [Related]
2. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein.
Morgan RW; Gelb J; Schreurs CS; Lütticken D; Rosenberger JK; Sondermeijer PJ
Avian Dis; 1992; 36(4):858-70. PubMed ID: 1485872
[TBL] [Abstract][Full Text] [Related]
3. Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens.
Heckert RA; Riva J; Cook S; McMillen J; Schwartz RD
Avian Dis; 1996; 40(4):770-7. PubMed ID: 8980804
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the onset of protection induced by Newcastle disease virus strain B1 and a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge.
King DJ
Avian Dis; 1999; 43(4):745-55. PubMed ID: 10611990
[TBL] [Abstract][Full Text] [Related]
5. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
[TBL] [Abstract][Full Text] [Related]
6. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens.
Reddy SK; Sharma JM; Ahmad J; Reddy DN; McMillen JK; Cook SM; Wild MA; Schwartz RD
Vaccine; 1996 Apr; 14(6):469-77. PubMed ID: 8782342
[TBL] [Abstract][Full Text] [Related]
7. Vaccination against Newcastle disease with a recombinant baculovirus hemagglutinin-neuraminidase subunit vaccine.
Nagy E; Krell PJ; Dulac GC; Derbyshire JB
Avian Dis; 1991; 35(3):585-90. PubMed ID: 1953580
[TBL] [Abstract][Full Text] [Related]
8. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
Kapczynski DR; King DJ
Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a turkey herpesvirus double construct vaccine (HVT-ND-IBD) against challenge with different strains of Newcastle disease, infectious bursal disease and Marek's disease viruses.
van Hulten MCW; Cruz-Coy J; Gergen L; Pouwels H; Ten Dam GB; Verstegen I; de Groof A; Morsey M; Tarpey I
Avian Pathol; 2021 Feb; 50(1):18-30. PubMed ID: 33063529
[TBL] [Abstract][Full Text] [Related]
10. Field trial in commercial broilers with a multivalent in ovo vaccine comprising a mixture of live viral vaccines against Marek's disease, infectious bursal disease, Newcastle disease, and fowl pox.
Sharma JM; Zhang Y; Jensen D; Rautenschlein S; Yeh HY
Avian Dis; 2002; 46(3):613-22. PubMed ID: 12243525
[TBL] [Abstract][Full Text] [Related]
11. Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.
Sonoda K; Sakaguchi M; Okamura H; Yokogawa K; Tokunaga E; Tokiyoshi S; Kawaguchi Y; Hirai K
J Virol; 2000 Apr; 74(7):3217-26. PubMed ID: 10708438
[TBL] [Abstract][Full Text] [Related]
12. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
Miller PJ; King DJ; Afonso CL; Suarez DL
Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a combination vaccine containing MDV CVI 988 strain and HVT against challenge with very virulent MDV.
Geerligs HJ; Weststrate MW; Pertile TL; Rodenberg J; Kumar M; Chu S
Acta Virol; 1999; 43(2-3):198-200. PubMed ID: 10696445
[TBL] [Abstract][Full Text] [Related]
14. Improved protection from velogenic Newcastle disease virus challenge following multiple immunizations with plasmid DNA encoding for F and HN genes.
Loke CF; Omar AR; Raha AR; Yusoff K
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):259-67. PubMed ID: 15963824
[TBL] [Abstract][Full Text] [Related]
15. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
[TBL] [Abstract][Full Text] [Related]
16. In ovo vaccination of specific-pathogen-free chickens with vaccines containing multiple agents.
Gagic M; St Hill CA; Sharma JM
Avian Dis; 1999; 43(2):293-301. PubMed ID: 10396643
[TBL] [Abstract][Full Text] [Related]
17. A double recombinant herpes virus of turkeys for the protection of chickens against Newcastle, infectious laryngotracheitis and Marek's diseases.
Gergen L; Cook S; Ledesma B; Cress W; Higuchi D; Counts D; Cruz-Coy J; Crouch C; Davis P; Tarpey I; Morsey M
Avian Pathol; 2019 Feb; 48(1):45-56. PubMed ID: 30404540
[TBL] [Abstract][Full Text] [Related]
18. Protection of chickens with or without maternal antibodies against both Marek's and Newcastle diseases by one-time vaccination with recombinant vaccine of Marek's disease virus type 1.
Sakaguchi M; Nakamura H; Sonoda K; Okamura H; Yokogawa K; Matsuo K; Hira K
Vaccine; 1998 Mar; 16(5):472-9. PubMed ID: 9491501
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a modified-live virus vaccine administered in ovo to protect chickens against Newcastle disease.
Ahmad J; Sharma JM
Am J Vet Res; 1992 Nov; 53(11):1999-2004. PubMed ID: 1466491
[TBL] [Abstract][Full Text] [Related]
20. A recombinant fowlpox virus vaccine expressing glycoprotein B gene from CVI988/Rispens strain of MDV: protection studies in different chickens.
Liu X; Peng D; Wu X; Xing L; Zhang R
Acta Virol; 1999; 43(2-3):201-4. PubMed ID: 10696446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
